SCYX Q1 2019 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$37M

Q1 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$64,000+0.0% YoY

Gross Profit

$64,000100.0% margin

Operating Income

-$12M-18532.8% margin

Net Income

-$23M-35793.8% margin

EPS (Diluted)

$-4.64

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$492,000

Balance Sheet

Total Assets

$45M

Total Liabilities

$34M

Stockholders' Equity

$11M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64,000	$64,000	+0.0%
Gross Profit	$64,000	$64,000	+0.0%
Operating Income	-$12M	-$7M	-64.0%
Net Income	-$23M	-$4M	-472.4%